Popular Articles

Lexicon Initiates Phase 2 Clinical Trial Of LX2931 In Patients With Rheumatoid Arthritis
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced that it has initiated a Phase 2 clinical trial of LX2931 in patients with rheumatoid arthritis. LX2931 is an orally-delivered, small molecule drug candidate that has recently completed Phase 1 testing in normal volunteers. Lexicon also successfully completed a drug-drug interaction (DDI) study of LX2931 with methotrexate in patients with rheumatoid arthritis, with no clinically significant drug-drug interactions observed.
diet pills
Enhanced Digital Breast Imaging From US Navy-Funded Technology
A breakthrough technology adapted for breast cancer detection based in part on research originally sponsored by the Office of Naval Research (ONR) is set to air July 23 during a CNN International news segment on Vital Signs, a program hosted by Dr. Sanjay Gupta.
News of the day
Op-Ed: Pres. Obama's Ghana Trip, Africa Policy
Obama"s Policy Could Make U.S.-Africa Relations "Flower"
Medical Devices

Fungi Pathogenic To Insects Are New Tool In Fight Against Chagas Disease

Entomopathogenic fungi may be a safe and efficient means of controlling Triatoma infestans, the bug that helps spread Chagas disease, according to new research conducted in Argentina. The study, published May 12 in the open-access journal PLoS Neglected Tropical Diseases, shows the success of the fungi to kill bugs resistant to current control methods. Chagas disease is the most relevant parasitic disease in Latin America, being a major burden that affects mostly poor human populations living in rural areas. The parasite Trypanosoma cruzi is mainly transmitted through blood-feeding triatomine bugs; in the southern Cone of South America the most prominent vector is Triatoma infestans. Current control strategies based on residual chemical insecticide application are threatened by the emergence of pyrethroid resistance. The researchers, led by Patricia Juç¡rez, performed both laboratory and field experiments showing that the entomopathogenic fungus Beauveria bassiana is virulent against bug populations from pyrethroid-resistant foci in the Argentina/Bolivia border. An attraction-infection trap was developed and tested during a 15-day period in field assays performed in two rural villages, demonstrating that more than 50% of the bugs detected were killed by fungal infection. By existing vector population models, the bug population reduction was estimated to reduce the risk of acquiring the parasite infection. This approach might also prove useful at different settings, e.g. peridomiciliary environments where current tactics and procedures are reported to fail, and rural communities located in remote areas inaccessible to sanitary control teams. The authors emphasize that these results might help to provide a safe and efficient alternative to overcome bug pyrethroid-resilience in the short term, and might be useful to control other Chagas disease vectors as well. Financial Disclosure: Partial financial support came from the Pan American Health Organization/World Health Organization/Special Program for Research and Training in Tropical Disease (A20433), the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (PICT 01-14174), and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina, to MPJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: NP, SJM, JRG, and MPJ have a patent pending on a blood-sucking insect trap, and a method to detect and control those insects. Citation: "Control of Pyrethroid-Resistant Chagas Disease Vectors with Entomopathogenic Fungi." Pedrini N, Mijailovsky SJ, Girotti JR, Stariolo R, Cardozo RM, et al. (2009) PLoS Negl Trop Dis 3(5): e434.doi:10.1371/journal.pntd.0000434 PLoS Neglected Tropical Diseases


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):